---
title: "Reagents and Bioinformatics analysis"
ocid: "ocds-r6ebe6-0000805164"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000805164"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000805164.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000805164.json"
source: "Public Contracts Scotland"
current_stage: "Award"
buyer: "NHS GRAMPIAN"
published: "2025-07-23"
---

# Reagents and Bioinformatics analysis

Buyer: NHS GRAMPIAN  
Current stage: Award  
OCID: ocds-r6ebe6-0000805164

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000805164)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000805164.json)

## Summary

NHS Grampian has concluded a procurement process for the supply of reagents and bioinformatics analysis related to Next Generation Sequencing (NGS) kits, essential for several national health services, including cancer and cardiac testing. The procurement, which falls under the health category and took place in Aberdeen, utilised a limited procedure, directly awarding the contract to SOPHiA GENETICS Ltd. This decision was made to ensure continuity in patient care, avoiding the significant delays and costs that would be incurred with alternate suppliers. The contract was signed on 21 July 2025, with an estimated value of £376,349 for the 2024-25 financial year.

This tender presents significant opportunities for businesses specialising in advanced genetic analysis and bioinformatics solutions within the health sector. Companies with established, integrated bioinformatics systems will find themselves well-suited to supply similar requisites, provided they can demonstrate specialised products that meet stringent healthcare standards. The contract's framework underscores the importance of established technical solutions and the potential for growth in servicing the public health system's complex needs, particularly those offering unique and validated products capable of enhancing healthcare service delivery.

## Notice

Next Generation Sequencing (NGS) kits

### Lot Information

Lot 1

Award value estimated based on previous spend for 2023-24 financial year. This is a direct award to the existing supplier to save a significant amount of rework that would be required if the genetics lab was to switch to an alternative supplier. This will cover the spend for 2024-25 financial year. It is vital that the supply of these items is uninterrupted as any delay will impact on patient care including cancer surgery / treatments, stem cell transplants for patients with primary immune deficiencies and bone marrow failure and correct patient management to prevent irreversible brain damage in metabolic conditions.

### Procurement Information

We have a number of services within the department that use Next Generation Sequencing (NGS) kits supplied by SOPHiA Genetics. These services are funded by National Services division (NSD) and the Aberdeen laboratory provides National services for Hereditary Breast, Ovarian and prostate cancer, Cardiac arrhythmias and Whole exome sequencing (for metabolic, gastrohepatology, chromosome breakage / inherited bone marrow failure and eye disorders) using these SOPHiA kits. These are essential established reagents used in these testing pathways, having previously undergone extensive validation processes within the laboratory. Purchase of alternative reagents would involve delay to testing as additional extensive validation work would need to be undertaken before use. An integral bioinformatics solution, SOPHiA DDM, is included in the price of these SOPHiA kits which provides cost-effective, streamlined analysis for these patient samples. In addition, SOPHiA DDM is used to analyse NGS data for other rare and inherited conditions using tailored analysis pipelines. This includes Primary Immune Deficiencies, Familial Hypercholesterolaemia and tumour testing for metastatic prostate cancer. This is charged on a cost per sample upload basis and allows clinical scientists to analyse the data in an efficient manner without the need for specialist bioinformaticians. Purchase of bioinformatics services from another provider would take a significant amount of time for the validation work required to ensure accurate results are obtained and would incur significant costs for extensive validation. Furthermore, additional staff would be required to perform the bioinformatics processes that would be required in the absence of the SOPHiA DDM platform for all of the national genetics services mentioned above. It is vital that the supply of these items is uninterrupted as any delay will impact on patient care including cancer surgery / treatments, stem cell transplants for patients with primary immune deficiencies and bone marrow failure and correct patient management to prevent irreversible brain damage in metabolic conditions.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL535288 |
| Notice type | OJEU - F3 - Contract Award Notice |
| Procurement type | Standard |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 23 Jul 2025 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 21 Jul 2025 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £376,349 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Not specified |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS GRAMPIAN |
| Locality | ABERDEEN |
| Post town | Aberdeen |
| Postcode | AB15 6RE |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM5 North Eastern Scotland |
| ITL 3 | TLM50 Aberdeen City and Aberdeenshire |
| Local authority | Aberdeen City |
| Electoral ward | Kingswells/Sheddocksley/Summerhill |
| Westminster constituency | Aberdeen North |
| Delivery location | TLM50 Aberdeen City and Aberdeenshire |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | SOPHIA GENETICS |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33696500 - Laboratory reagents

## Release History

- 23 Jul 2025 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL535288

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL535288
  Reagents and Bioinformatics analysis - Next Generation Sequencing (NGS) kits

## Notice URLs

- http://
- http://www.nhsgrampian.org
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000805164

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000805164. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000805164.json.